Filter announcements
Loading...
Orchid Pharma is a pharmaceutical company engaged in the development and manufacture of active pharmaceutical ingredients (APIs) and finished dosage forms. It is also engaged in research of new drugs.
Orchid Pharma Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2025-26'.
Orchid Pharma's Whole Time Director will participate in an Investor Roadshow in Singapore. The company assures that no unpublished price sensitive information will be shared during these investor meetings.
Orchid Pharma's Scheme of Amalgamation with Dhanuka Laboratories Limited is now effective. Dhanuka Laboratories has officially merged with Orchid Pharma and stands dissolved, completing this significant business development.
Orchid Pharma Limited has informed the Exchange regarding 'Update on Scheme of Arrangement' that in continuation of our earlier intimations dated March 18, 2026, with respect to the merger petition, we would like to inform that Hon ble National Company Law Tribunal, Chennai ( NCLT ) on June 05, 2026,...
Orchid Pharma's Whole Time Director will participate in an Investor Roadshow in Gurugram for a group meet. The company stated no Unpublished Price Sensitive Information will be shared during the engagement.